Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 24, 1437-1447, September 1, 1964]
© 1964 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolberg, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolberg, W. H.

Studies on the Mechanism of Human Tumor Resistance to the Fluorinated Pyrimidines*

William H. Wolberg

( Department of Surgery and Division of Clinical Oncology, The Medical School, University of Wisconsin, Madison, Wisconsin)

The in vitro effect of fluorinated pyrimidines on uridine and thymidine incorporation into DNA and the subsequent clinical responses to fluorinated pyrimidine chemotherapy was studied in 55 human tumors. In some cases tumor resistance was attributed to a deficiency of the enzymes which are required for converting 5-fluorouracil or 5-fluoro-2'-deoxyuridine to the active compound, 5-fluoro-2'-deoxyuridine-5-monophosphate. In other tumors where these enzymes were present but the incorporation of uridine and thymidine was not affected by the fluorinated pyrimidines, an insensitive thymidylate synthetase was implicated as the cause of tumor resistance. This report is an extension to human tumors of the work by other investigators who studied the problem of fluorinated pyrimidine resistance in experimental animal tumors.

* This work was supported in part by grants CA05953 and CA06749 from the United States Public Health Service, National Institutes of Health, Bethesda, Maryland.

Received 4/ 2/64.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1964 by the American Association for Cancer Research.